Non-small cell lung cancer: Clinical practice guidelines in oncology

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of The National Comprehensive Cancer Network

• Publication date

  2006-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.6004/JNCCN.2010.0056
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer.

  2008cited by this paper
• Non-small cell lung cancer with ipsilateral pulmonary metastases: prognosis analysis and staging assessment.

  2008cited by this paper
• Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study).

  2008cited by this paper
• Phase III Trial Comparing Paclitaxel Poliglumex (CT-2103, PPX) in Combination with Carboplatin Versus Standard Paclitaxel and Carboplatin in the Treatment of PS 2 Patients with Chemotherapy-Naïve Advanced Non-small Cell Lung Cancer

  2008cited by this paper
• Somatic mutations affect key pathways in lung adenocarcinoma

  2008cited by this paper
• Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer.

  2008cited by this paper
• Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023.

  2008cited by this paper
• The significance of intrapulmonary metastasis in non-small cell lung cancer: upstaging or downstaging? A re-appraisal for the next TNM staging system.

  2008cited by this paper
• The molecular genetics of lung cancer.

  2008cited by this paper
• Video-assisted thoracic surgery sleeve lobectomy: a case series.

  2008cited by this paper
• Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.

  2008cited by this paper
• Molecular characteristics of bronchioloalveolar carcinoma and adenocarcinoma, bronchioloalveolar carcinoma subtype, predict response to erlotinib.

  2008cited by this paper
• Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.

  2008cited by this paper
• International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways.

  2008cited by this paper
• Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.

  2008cited by this paper
• Cell-free DNA resuscitated for tumor testing

  2008cited by this paper
• Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine plus Docetaxel in Non-Small-Cell Lung Cancer Patients

  2008cited by this paper
• Surgery for early-stage non-small cell lung cancer: a systematic review of the video-assisted thoracoscopic surgery versus thoracotomy approaches to lobectomy.

  2008cited by this paper
• Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.

  2008cited by this paper
• Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.

  2008cited by this paper
• EGFR Assays in Lung Cancer

  2008cited by this paper
• Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study.

  2008cited by this paper
• Does PET/CT modify the therapeutic approach in medical oncology?

  2008cited by this paper
• Detection of mutations in EGFR in circulating lung-cancer cells.

  2008cited by this paper
• Is video-assisted thoracic surgery lobectomy better? Quality of life considerations.

  2008cited by this paper
• Palliative thoracic radiotherapy for lung cancer: a systematic review.

  2008cited by this paper
• Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk?

  2008cited by this paper
• Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.

  2008cited by this paper
• Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

  2008cited by this paper
• Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer.

  2008cited by this paper
• Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group.

  2008cited by this paper
• Thoracoscopic lobectomy: report on safety, discharge independence, pain, and chemotherapy tolerance.

  2008cited by this paper
• Prognostic implications of normal (<0.10 ng/ml) and borderline (0.10 to 1.49 ng/ml) troponin elevation levels in critically ill patients without acute coronary syndrome.

  2008cited by this paper
• Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801.

  2008cited by this paper
• Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology.

  2008cited by this paper
• Systemic chemotherapy for advanced non-small cell lung cancer: recent advances and future directions.

  2008cited by this paper
• Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.

  2008cited by this paper
• EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers

  2008cited by this paper
• Use of video-assisted thoracic surgery for lobectomy in the elderly results in fewer complications.

  2008cited by this paper
• Impact of FDG-PET/CT on radiotherapy volume delineation in non-small-cell lung cancer and correlation of imaging stage with pathologic findings.

  2008cited by this paper
• The use of blood biomarkers to predict radiation lung toxicity: a potential strategy to individualize thoracic radiation therapy.

  2008cited by this paper
• Video-assisted thoracoscopic lobectomy: state of the art and future directions.

  2008cited by this paper
• Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis.

  2008cited by this paper
• EML4-ALK Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer

  2008cited by this paper
• Noninvasive monitoring of tumors.

  2008cited by this paper
• Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer.

  2008cited by this paper
• Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.

  2008cited by this paper
• Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial

  2008cited by this paper
• First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations.

  2008cited by this paper
• Just enough palliation: radiation dose and outcome in patients with non-small-cell lung cancer.

  2008cited by this paper
• Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update.

  2008cited by this paper
• ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel

  2008cited by this paper
• Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors.

  2008cited by this paper
• Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases: A Randomized Controlled Trial

  2007cited by this paper
• Significance of extranodal extension of regional lymph nodes in surgically resected non-small cell lung cancer.

  2007cited by this paper
• Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC).

  2007cited by this paper
• Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

  2007cited by this paper
• Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.

  2007cited by this paper
• Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations.

  2007cited by this paper
• EGFR and HER2 Gene Copy Number and Response to First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)

  2007cited by this paper
• DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.

  2007cited by this paper
• Epidermal growth factor receptor mutations in lung cancer

  2007cited by this paper
• Detection of extrapulmonary lesions with integrated PET/CT in the staging of lung cancer

  2007cited by this paper
• Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.

  2007cited by this paper
• Paclitaxel/Carboplatin/gemcitabine versus gemcitabine/vinorelbine in advanced non-small-cell lung cancer: a phase II/III study of the Minnie Pearl Cancer Research Network.

  2007cited by this paper
• Natural history of stage I non-small cell lung cancer: implications for early detection.

  2007cited by this paper
• Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.

  2007cited by this paper
• Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent.

  2007cited by this paper
• Lung cancer in never smokers: a review.

  2007cited by this paper
• Response to treatment and survival of patients with non-small cell lung cancer undergoing somatic EGFR mutation testing.

  2007cited by this paper
• Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer.

  2007cited by this paper
• Lung cancer in never smokers — a different disease

  2007cited by this paper
• Video-Assisted Thoracic Surgery in Lung Cancer Resection

  2007cited by this paper
• Video-assisted thoracic surgery lobectomy: report of CALGB 39802--a prospective, multi-institution feasibility study.

  2007cited by this paper
• A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer.

  2007cited by this paper
• Epidermal Growth Factor Receptor Mutation Testing in Lung Cancer: Searching for the Ideal Method

  2007cited by this paper
• The IASLC Lung Cancer Staging Project: Validation of the Proposals for Revision of the T, N, and M Descriptors and Consequent Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

  2007cited by this paper
• Prognostic and predictive importance of p53 and RAS for adjuvant chemotherapy in non small-cell lung cancer.

  2007cited by this paper
• Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).

  2007cited by this paper
• Evidence-Based Clinical Practice Guidelines Initial Diagnosis of Lung Cancer : ACCP

  2007cited by this paper
• Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study

  2007cited by this paper
• Effects of Postoperative Mediastinal Radiation on Completely Resected Stage 11 and Stage Ill Epidermoid Cancer of the Lung * LCSG 773

  2007cited by this paper
• UC Davis UC Davis Previously Published Works Title The early detection of second primary lung cancers by sputum immunostaining

  2007cited by this paper
• Frequency of local recurrence following segmentectomy of stage IA non-small cell lung cancer is influenced by segment localisation and width of resection margins--implications for patient selection for segmentectomy.

  2007cited by this paper
• Surgical treatment of synchronous multiple primary lung cancers: experience of 92 patients.

  2007cited by this paper
• Prospective Assessment of Discontinuation and Reinitiation of Erlotinib or Gefitinib in Patients with Acquired Resistance to Erlotinib or Gefitinib Followed by the Addition of Everolimus

  2007cited by this paper
• Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer

  2007cited by this paper
• Involved-field radiation therapy for inoperable non small-cell lung cancer.

  2007cited by this paper
• Video-Assisted Thoracic Surgery (VATS) Lobectomy: the Evidence Base

  2007cited by this paper
• A Critical Look at the Role of Chemotherapy in Older Patients with Non-small Cell Lung Cancer

  2007cited by this paper
• Induction chemotherapy does not increase the operative risk of pneumonectomy!

  2007cited by this paper
• Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study

  2007cited by this paper
• High-Dose Radiotherapy for the Treatment of Inoperable Non–Small Cell Lung Cancer

  2007cited by this paper
• The UDP-Glucuronosyltransferase 2B17 Gene Deletion Polymorphism: Sex-Specific Association with Urinary 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol Glucuronidation Phenotype and Risk for Lung Cancer

  2007cited by this paper
• Pulmonary segmentectomy by thoracotomy or thoracoscopy: reduced hospital length of stay with a minimally-invasive approach.

  2007cited by this paper
• Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition).

  2007cited by this paper
• The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

  2007cited by this paper
• Case-control study of human papillomavirus and oropharyngeal cancer.

  2007cited by this paper
• Video-assisted thoracoscopic surgery is more favorable than thoracotomy for resection of clinical stage I non-small cell lung cancer.

  2007cited by this paper
• Computed tomography screening and lung cancer outcomes.

  2007cited by this paper

• Clinically relevant somatic variants and genomic discordance between primary tumors and mediastinal lymph nodes in lung adenocarcinoma

  2026cites this paper
• CircPTK2 enhances non‐small cell lung cancer proliferation by inhibiting cellular senescence through stabilizing NFYA and elevating FOXM1

  2025cites this paper
• Self-assembled nano-hybrid composite based on Cu/CuXO nanoflower decorated onto hBNNS for high-performance and ultra-sensitive electrochemical detection of CEA biomarker.

  2025cites this paper
• The Prognostic Value of the Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score in Lung Cancer: A Systematic Review and Meta-Analysis

  2025cites this paper
• Application of 3-dimensional reconstruction via modified pulmonary artery computed tomography angiography in anatomic pulmonary segmentectomy

  2025cites this paper
• Comparison of first and third generation EGFR-TKIs for the treatment of advanced non-small cell lung cancer: A real-world study.

  2025cites this paper
• The lysosomal cysteine protease cathepsin L promotes stemness and multidrug resistance of non-small cell lung cancer by targeting HGF activator.

  2025cites this paper
• Proposal of real-world solutions for the implementation of predictive biomarker testing in patients with operable non-small cell lung cancer.

  2025cites this paper
• Integrative Mendelian randomization and spatial transcriptomics analysis reveals causal links between plasma lipidome and non–small cell lung cancer

  2025cites this paper
• The (re)emergence of aerosol delivery: Treatment of pulmonary diseases and its clinical challenges.

  2025cites this paper
• Adherence to Posttreatment Surveillance Guidelines in Non–Small Cell Lung Cancer: Retrospective Cohort Study

  2025cites this paper
• Thoracotomy is better than minimally invasive thoracoscopic lobectomy in the lymph node dissection of lung cancer: A systematic review and meta-analysis

  2025cites this paper
• Analysis and Characterization of Chondroitin/Dermatan Sulfate Composition of Lung Adenocarcinoma Tissues with Different Types of Genetic Alterations in ALK, EGFR and KRAS Oncogenes

  2025cites this paper
• Prevalence, therapeutic approaches, and survival rates of brain metastases in non-small cell lung cancer: a multi-institutional claims-based study from 2014 to 2024

  2025cites this paper
• Development and validation of a quick and sensitive UPLC-MS/MS method for measuring ensartinib in HLMs: investigation of structural alerts associated with metabolic lability and in silico toxicity.

  2025cites this paper
• Atorvastatin exhibits anticancer effects by inhibiting YAP/TAZ activity in mesenchymal-like non-small cell lung cancer

  2025cites this paper
• The safety and efficacy of binimetinib for lung cancer: a systematic review

  2024cites this paper
• Texture and Radiomics inspired Data-Driven Cancerous Lung Nodules Severity Classification

  2024cites this paper
• Survival and recurrence rates following SBRT or surgery in medically operable Stage I NSCLC.

  2024cites this paper
• An ultra-fast green ultra-high-performance liquid chromatography-tandem mass spectrometry method for estimating the in vitro metabolic stability of zotizalkib in human liver microsomes.

  2024cites this paper
• Novel insights into the International Association for the Study of Lung Cancer grading system for lung adenocarcinoma.

  2024cites this paper
• Pro-survival roles for p21(Cip1/Waf1) in non-small cell lung cancer

  2024influential citation
• Ultra-fast UPLC-MS/MS approach for estimating X-376 in human liver microsomes: Evaluation of metabolic stability via in silico software and in vitro analysis.

  2024cites this paper
• Identification of the Prognostic Factors for Synchronous Multiple Primary Lung Cancer Treated With Staged Bilateral Surgery

  2024cites this paper
• The Impact of a Multidisciplinary Team Conference on Non-Small Cell Lung Cancer Care: Time Barriers and Long-Term Outcomes

  2024cites this paper
• Characterization of the in vitro metabolic profile of nazartinib in HLMs using UPLC-MS/MS method: In silico metabolic lability and DEREK structural alerts screening using StarDrop software

  2024cites this paper
• Real-world relationship of early endpoints to survival endpoints in patients with resectable non-small-cell lung cancer.

  2023cites this paper
• The synergistic effect of PET/MRI in whole-body oncologic imaging: an Expert Review

  2023cites this paper
• A Systems Biology Approach for Addressing Cisplatin Resistance in Non-Small Cell Lung Cancer

  2023cites this paper
• The role of targeted therapy and immune therapy in the management of non-small cell lung cancer brain metastases

  2023cites this paper
• Evaluation of Zerumbone as an EGFR Tyrosine Kinase Inhibitor by Molecular Docking Method

  2023cites this paper
• MAPKAPK5-AS1/miR-515-5p/CAB39 Axis Contributes to Non-small Cell Lung Cancer Cell Proliferation and Migration

  2023cites this paper
• Olaparib maintenance versus placebo in platinum-sensitive non-small cell lung cancer: the Phase 2 randomized PIPSeN trial

  2023influential citation
• Evaluation of Alectinib Metabolic Stability in HLMs Using Fast LC-MS/MS Method: In Silico ADME Profile, P450 Metabolic Lability, and Toxic Alerts Screening

  2023cites this paper
• The key role of microRNA-766 in the cancer development

  2023cites this paper
• An association of epidermal growth factor receptor mutation subtypes with prognostic prediction and site-specific recurrence in advanced stage lung cancer patients

  2023cites this paper
• The role of macrophages in non-small cell lung cancer and advancements in 3D co-cultures

  2023cites this paper
• Comparison Results of Three-Port Robot-Assisted and Uniportal Video-Assisted Lobectomy for Functional Recovery Index in the Treatment of Early Stage Non-small Cell Lung Cancer: A Propensity Score-Matched Analysis

  2023cites this paper
• Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors

  2023cites this paper
• Impact of feature harmonization on radiogenomics analysis: Prediction of EGFR and KRAS mutations from non-small cell lung cancer PET/CT images

  2022cites this paper
• Unravelling hub genes as potential therapeutic targets in lung cancer using integrated transcriptomic meta-analysis and in silico approach

  2022cites this paper
• Datele din lumea reală şi studiile clinice pentru evaluarea eficacităţii noilor terapii oncologice. Rolul studiilor observaţionale, cu exemplificare în cancerul pulmonar fără celule mici (NSCLC)

  2022cites this paper
• Phytochemicals from Allium tuberosum Rottler ex Spreng Show Potent Inhibitory Activity against B-Raf, EGFR, K-Ras, and PI3K of Non-Small Cell Lung Cancer Targets

  2022cites this paper
• Radiomics and deep learning methods for the prediction of 2-year overall survival in LUNG1 dataset

  2022cites this paper
• A Novel Strategy for Identifying NSCLC MicroRNA Biomarkers and Their Mechanism Analysis Based on a Brand-New CeRNA-Hub-FFL Network

  2022cites this paper
• Oncogenic EFNA4 Amplification Promotes Lung Adenocarcinoma Lymph Node Metastasis

  2022cites this paper
• Efficient Machine Learning Techniques to Predict Lung Cancer

  2022cites this paper
• Oridonin-loaded lipid-coated calcium phosphate nanoparticles: preparation, characterization, and application in A549 lung cancer

  2022cites this paper
• In Silico Prospects and Therapeutic Applications of Ouabagenin and Hydroxylated Corticosteroid Analogues in the Treatment of Lung Cancer

  2022cites this paper
• Estimation of zorifertinib metabolic stability in human liver microsomes using LC-MS/MS.

  2022cites this paper
• Crucial Roles of miR-625 in Human Cancer

  2022cites this paper
• Revisiting segmentation of lung tumors from CT images

  2022cites this paper
• Percentage of Newly Proposed High-Grade Patterns Is Associated with Prognosis of Pathological T1-2N0M0 Lung Adenocarcinoma

  2022cites this paper
• Fused feature signatures to probe tumour radiogenomics relationships

  2022cites this paper
• CircPVT1: a pivotal circular node intersecting Long Non-Coding-PVT1 and c-MYC oncogenic signals

  2022cites this paper
• MiR-139-3p Targets CHEK1 Modulating DNA Repair and Cell Viability in Lung Squamous Carcinoma Cells

  2022cites this paper
• The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer

  2022cites this paper
• Photodynamic therapy for stage I and II non-small cell lung cancer

  2022cites this paper
• The malignant property of circHIPK2 for angiogenesis and chemoresistance in non-small cell lung cancer.

  2022cites this paper
• Integrating microRNA expression, miRNA-mRNA regulation network and signal pathway: a novel strategy for lung cancer biomarker discovery

  2021cites this paper
• SNX20 Expression Correlates with Immune Cell Infiltration and Can Predict Prognosis in Lung Adenocarcinoma

  2021cites this paper
• The Importance of Clinical Decision-Making in Surgical Planning for Non-Small Cell Lung Cancer

  2021cites this paper
• Immune‐related eight‐lncRNA signature for improving prognosis prediction of lung adenocarcinoma

  2021cites this paper
• A dual-signal amplification photoelectrochemical immunosensor for ultrasensitive detection of CYFRA 21-1 based on the synergistic effect of SnS2/SnS/Bi2S3 and ZnCdS@NPC-ZnO

  2021cites this paper
• Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung Cancer

  2021cites this paper
• LC–MS/MS Estimation of Rociletinib Levels in Human Liver Microsomes: Application to Metabolic Stability Estimation

  2021cites this paper
• Dysregulated ferroptosis‐related genes indicate potential clinical benefits for anti–PD‐1/PD‐L1 immunotherapy in lung adenocarcinoma

  2021cites this paper
• Alpha-Solanine Anti-Tumor Effects in Non-Small Cell Lung Cancer Through Regulating the Glycolysis Pathway

  2021cites this paper
• Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitors

  2021cites this paper
• An [18F]FDG-PET/CT deep learning method for fully automated detection of pathological mediastinal lymph nodes in lung cancer patients

  2021cites this paper
• Treatment Patterns, Disparities, and Management Strategies Impact Clinical Outcomes in Patients with Symptomatic Severe Aortic Regurgitation

  2021cites this paper
• Circadian Rhythm Is Disrupted by ZNF704 in Breast Carcinogenesis

  2020cites this paper
• Circular RNA circABCC4 regulates lung adenocarcinoma progression via miR‐3186‐3p/TNRC6B axis

  2020cites this paper
• PRKCZ-AS1 promotes the tumorigenesis of lung adenocarcinoma via sponging miR-766-5p to modulate MAPK1

  2020cites this paper
• Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients

  2020cites this paper
• Effective targeting of the ubiquitin-like modifier NEDD8 for lung adenocarcinoma treatment

  2020cites this paper
• The role of Self Nano Emulsifying drug delivery systems of CDODA-Me in sensitizing Erlotinib resistant Nonsmall cell lung cancer.

  2020cites this paper
• The Phenoxyphenol Compound 4-HPPP Selectively Induces Antiproliferation Effects and Apoptosis in Human Lung Cancer Cells through Aneupolyploidization and ATR DNA Repair Signaling

  2020cites this paper
• Preoperative Evaluation: Frailty Parameters, Preoperative Neoadjuvant Therapy—Indications for Postoperative Care Unit

  2020cites this paper
• Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis

  2020cites this paper
• Prognostic Impact of Postoperative Skeletal Muscle Decrease in Non-Small Cell Lung Cancer.

  2020cites this paper
• Evaluation of the use of non-formulary oncology medications restricted to outpatient use in hospitalized patients after implementation of a criteria-for-use algorithm

  2020cites this paper
• Characterization of Stable and Reactive Metabolites of the Anticancer Drug, Ensartinib, in Human Liver Microsomes Using LC-MS/MS: An in silico and Practical Bioactivation Approach

  2020cites this paper
• Peripheral blood lymphocytes and platelets are prognostic in surgical pT1 non-small cell lung cancer.

  2020cites this paper
• Linc00426 accelerates lung adenocarcinoma progression by regulating miR-455-5p as a molecular sponge

  2020cites this paper
• SNHG3 Knockdown Suppresses Proliferation, Migration and Invasion, and Promotes Apoptosis in Non-Small Cell Lung Cancer Through Regulating miR-216a/ZEB1 Axis

  2020cites this paper
• Impact of preexisting antinuclear antibodies on combined immunotherapy and chemotherapy in advanced non-small cell lung cancer patients

  2020cites this paper
• LncRNA HAND2-AS1 inhibits proliferation and promotes apoptosis of non-small cell lung cancer cells by inactivating PI3K/Akt pathway

  2020cites this paper
• Genetic profiling of primary and secondary tumors from patients with lung adenocarcinoma and bone metastases reveals targeted therapy options

  2020cites this paper
• Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naïve Non-Small Cell Lung Cancer.

  2020cites this paper
• Targeted Radionuclide Therapy in Patient-Derived Xenografts Using 177Lu-EB-RGD

  2020cites this paper
• Combination of DN604 with gemcitabine led to cell apoptosis and cell motility inhibition via p38 MAPK signaling pathway in NSCLC.

  2020cites this paper
• Evaluation of sensitivity and specificity of CanPatrol™ technology for detection of circulating tumor cells in patients with non-small cell lung cancer

  2020cites this paper
• Prognostic Impact of Smoking Period in Patients with Surgically Resected Non-small Cell Lung Cancer

  2020cites this paper
• LUNG CANCER - STATISTICAL ANALYSIS DATA IN A 5 YEAR PERIOD IN BITOLA, REPUBLIC OF NORTH MACEDONIA

  2020cites this paper
• Long non‐coding RNA CASC19 facilitates non‐small cell lung cancer cell proliferation and metastasis by targeting the miR‐301b‐3p/LDLR axis

  2020cites this paper
• EGFR testing and erlotinib use in non-small cell lung cancer patients in Kentucky

  2020cites this paper
• Surgical Compliance and Survival Outcomes for Patients with Stage T1-2 Non-Small-Cell Lung Cancer

  2020cites this paper
• IMMUNOTERAPİ VE RADYOTERAPİ KOMBİNASYONU

  2020cites this paper
• Comprehensive analysis of the expression and prognosis for TFAP2 in human lung carcinoma

  2020cites this paper